S 2644
106th Congress
Senate
Access to Innovation for Medicare Patients Act of 2000
Official title: A bill to amend title XVIII of the Social Security Act to expand medicare coverage of certain self-injected biologicals.
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 25, 2000
Read twice and referred to the Committee on Finance.
May 25, 2000
Sponsor introductory remarks on measure. (CR S4477-4478)
May 25, 2000
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Read twice and referred to the Committee on Finance.
Plain-English summary
Access to Innovation for Medicare Patients Act of 2000 - Amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage of self-injected biologicals approved by the Food and Drug Administration that are prescribed as a complete replacement for a drug or a biological that otherwise cannot be self-administered.
Bill text
1 version
- Introduced in Senate Formatted Text PDF
Committees of jurisdiction
1
Cosponsors
2
Cite this page
U.S. Congress. (2026). S. 2644: Access to Innovation for Medicare Patients Act of 2000. 106th Congress. Open America. https://openamerica.io/bill/106-S-2644/
"S. 2644: Access to Innovation for Medicare Patients Act of 2000." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-S-2644/.
S. 2644, 106th Cong. (2026), https://openamerica.io/bill/106-S-2644/.
[S. 2644: Access to Innovation for Medicare Patients Act of 2000](https://openamerica.io/bill/106-S-2644/)